121 related articles for article (PubMed ID: 8099532)
1. Prognostic value of proliferating cell nuclear antigen in lymph node-negative breast cancer patients.
Bianchi S; Paglierani M; Zampi G; Cardona G; Cataliotti L; Bonardi R; Zappa M; Ciatto S
Cancer; 1993 Jul; 72(1):120-5. PubMed ID: 8099532
[TBL] [Abstract][Full Text] [Related]
2. Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score.
Tahan SR; Neuberg DS; Dieffenbach A; Yacoub L
Cancer; 1993 Jun; 71(11):3552-9. PubMed ID: 8098267
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of cell proliferation in breast cancer as determined by proliferating cell nuclear antigen (PCNA) immunostaining.
Aaltomaa S; Lipponen P; Syrjänen K
Anticancer Res; 1992; 12(4):1281-6. PubMed ID: 1380227
[TBL] [Abstract][Full Text] [Related]
4. Poor prognostic value of proliferating cell nuclear antigen labelling index in breast carcinoma.
Thomas M; Noguchi M; Kitagawa H; Kinoshita K; Miyazaki I
J Clin Pathol; 1993 Jun; 46(6):525-8. PubMed ID: 8101192
[TBL] [Abstract][Full Text] [Related]
5. Proliferating-cell nuclear antigen (PC10) immunolabelling and other proliferation indices as prognostic factors in breast cancer.
Aaltomaa S; Lipponen P; Papinaho S; Syrjänen K
J Cancer Res Clin Oncol; 1993; 119(5):288-94. PubMed ID: 8095051
[TBL] [Abstract][Full Text] [Related]
6. Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis.
Narita T; Funahashi H; Satoh Y; Takagi H
Jpn J Clin Oncol; 1993 Feb; 23(1):20-5. PubMed ID: 8096256
[TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of proliferating cell nuclear antigen in patients with lymph node-positive breast cancer.
Sheen-Chen SM; Eng HL; Chou FF; Chen WJ
Arch Surg; 1997 Mar; 132(3):264-7. PubMed ID: 9125025
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinoma breast.
Aziz SA; Pervez S; Khan SM; Kayani N; Nasir MI
J Coll Physicians Surg Pak; 2005 Apr; 15(4):225-9. PubMed ID: 15857596
[TBL] [Abstract][Full Text] [Related]
9. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.
Siitonen SM; Kallioniemi OP; Isola JJ
Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759
[TBL] [Abstract][Full Text] [Related]
10. Proliferating cell nuclear antigen (PCNA) immunolabeling as a prognostic factor in axillary lymph node negative breast cancer.
Aaltomaa S; Lipponen P; Syrjänen K
Anticancer Res; 1993; 13(2):533-8. PubMed ID: 8100128
[TBL] [Abstract][Full Text] [Related]
11. Cell proliferation in breast carcinoma assessed by a PCNA grading system and its relation to other prognostic variables.
Betta PG; Bottero G; Pavesi M; Pastormerlo M; Bellinger D; Tallarida F
Surg Oncol; 1993; 2(1):59-63. PubMed ID: 7902763
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of proliferating cell nuclear antigen and c-erbB-2 compared with conventional histopathological factors in breast cancer.
Schönborn I; Zschiesche W; Minguillon C; Spitzer E; Möhner M; Ebeling K; Grosse R
J Cancer Res Clin Oncol; 1995; 121(2):115-22. PubMed ID: 7883773
[TBL] [Abstract][Full Text] [Related]
13. Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value.
Lipponen PK; Eskelinen MJ
Br J Cancer; 1992 Jul; 66(1):171-6. PubMed ID: 1353364
[TBL] [Abstract][Full Text] [Related]
14. C-erbB-2 and PCNA as prognostic indicators of long-term survival in breast cancer.
Kato T; Kameoka S; Kimura T; Nishikawa T; Kobayashi M
Anticancer Res; 2002; 22(2B):1097-103. PubMed ID: 12168907
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of proliferating cell nuclear antigen in clinical gastric cancer.
Mori M; Kakeji Y; Adachi Y; Moriguchi S; Maehara Y; Sugimachi K; Jessup JM; Chen LB; Steele GD
Surgery; 1993 Jun; 113(6):683-90. PubMed ID: 8099452
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of proliferating cell nuclear antigen (PCNA) expression in non-small cell lung cancer.
Fujii M; Motoi M; Saeki H; Aoe K; Moriwaki S
Acta Med Okayama; 1993 Apr; 47(2):103-8. PubMed ID: 8099466
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of the combined assessment of proliferating cell nuclear antigen immunostaining and nuclear DNA content in invasive human mammary carcinomas.
Schimmelpenning H; Eriksson ET; Franzén B; Zetterberg A; Auer GU
Virchows Arch A Pathol Anat Histopathol; 1993; 423(4):273-9. PubMed ID: 7901939
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinomas: comparison with clinical and pathologic variables.
Frierson HF
Mod Pathol; 1993 May; 6(3):290-4. PubMed ID: 8102204
[TBL] [Abstract][Full Text] [Related]
20. Correlation of proliferative index (PCNA reactivity and Ki-67 reactivity) in primary breast carcinoma with hormone status, lymph node status, and disease-free survival.
Magno WB; Hirschfield L; Bhuiya T; Harrison G; Mir R
Conn Med; 1992 Dec; 56(12):667-9. PubMed ID: 1363223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
